{"nct_id":"NCT05669989","title":"International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-01","start_date":"2023-04-05","start_date_type":"ACTUAL","primary_completion_date":"2026-11-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-11-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["SNY"]}